Clinical Trials Logo

Hematologic Malignancy clinical trials

View clinical trials related to Hematologic Malignancy.

Filter by:

NCT ID: NCT02512666 Completed - Clinical trials for Hematologic Malignancy

Non Invasive Optical Imaging of WBC Count

Start date: September 2015
Phase: N/A
Study type: Interventional

This research study is looking at a small device that measures white blood cell (WBC) counts by being placed against the finger nail for participants who are undergoing stem cell transplantation at Massachusetts General Hospital or have a hematologic malignancy and are being seen as an outpatient.

NCT ID: NCT02385955 Not yet recruiting - Clinical trials for Hematologic Malignancy

Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients

Start date: April 2015
Phase: Phase 2
Study type: Interventional

This study aimed to evaluate the efficacy and safety of myeloablative double unit umbilical cord blood transplantation (dUCBT) in adult patients with hematologic malignancies. Two myeloablative conditioning regimens will be used in this study: (1) total body irradation (TBI), cyclophosphamide, and cytarabine, or (2) thiotepa, busulfan, and fludarabine.

NCT ID: NCT02359838 Completed - Clinical trials for Hematologic Malignancy

Patient-Centered Care for the Older Adult With Hematologic Malignancy

Start date: February 1, 2015
Phase: N/A
Study type: Interventional

This research study is evaluating if co-management by a geriatrician embedded in the oncology clinic can improve outcomes for frail older adults with blood cancers. A rigorous pre-entry frailty assessment by a trained research assistant will be followed by randomization to geriatrician co-management versus usual care for patients found to be frail or pre-frail.

NCT ID: NCT02352558 Completed - Clinical trials for Hematologic Malignancy

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Start date: May 2015
Phase: Phase 1
Study type: Interventional

This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 administered to patients with relapsed, refractory hematologic malignancies, including multiple myeloma, lymphoma, and others.

NCT ID: NCT02207764 Withdrawn - Clinical trials for Hematologic Malignancy

Reiki as a Complementary Therapy: A Pilot Study

Start date: September 2014
Phase: N/A
Study type: Interventional

This research is being done to test whether a complementary intervention, Reiki therapy, can provide added benefits to the standard patient care. Reiki is method for stress reduction that uses hand positions over and/or on the body to help people relax. We are studying the effect of a 15-minute Reiki application compared to an intervention of nursing presence without Reiki. We hope to find if Reiki can assist in relieving stress, and improving patient outcomes. In the future we would like to offer complementary interventions as an adjunct to our standard care for patients.

NCT ID: NCT02193399 Not yet recruiting - Clinical trials for Hematologic Malignancy

Physiotherapy in Hematopoietic Stem Cell Transplantation

TRAS
Start date: September 2014
Phase: N/A
Study type: Interventional

Research project with patients undergoing allogeneic hematopoietic transplantation in the hematology and hemotherapy Clinical Hospital Universitario Virgen de la Arrixaca. The main objective is to assess the differences in skeletal muscle and functional variables in the experimental group underwent a physiotherapy treatment that takes place during the pre-and post-transplant period, compared to a control group.

NCT ID: NCT02134574 Recruiting - Clinical trials for Hematologic Malignancy

Prospective Cohort With Hemopathy in Languedoc-Roussillon

HemoDiag
Start date: February 2014
Phase:
Study type: Observational

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.

NCT ID: NCT02049424 Terminated - Clinical trials for Hematologic Malignancy

Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow

Start date: March 2011
Phase: N/A
Study type: Observational

Outcome evaluation in patients who underwent transplantation with T-repleted bone marrow after post-transplantation cyclophosphamide

NCT ID: NCT02042924 Terminated - Clinical trials for Hematologic Malignancy

Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies

Start date: January 2014
Phase: N/A
Study type: Interventional

This is a pilot sub-study of patients receiving myeloablative transplant using total body irradiation (TBI) or total marrow irradiation (TMI) in their preparative regimen. The objective of this stub-study is to estimate the heterogeneity in cellular proliferation (FLT-PET uptake) as well the heterogeneity in marrow composition distribution (measured using whole body water-fat MRI) using positron emission tomography imaging. This will be used to design future trials as well as to determine the feasibility of PET and MRI imaging.

NCT ID: NCT02041416 Active, not recruiting - Cancer Clinical Trials

Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

Start date: May 15, 2013
Phase:
Study type: Observational

The goal of this study is to determine the feasibility, reliability, and validity of administering the Geriatric Assessment Tool using these two different computer based survey platforms, REDCap and Support Screen. The development of a computer based Geriatric Assessment Tool has the potential to improve research and clinical practice by providing an efficient user friendly means to collect and analyze data for geriatric oncology patients.